Physician profile
Anna Everett
NPI 1780144626
$585.80
in general payments reported to CMS, 2019-2025
10 companies · $53.34 in 2025
The $53.34 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $137 · 2023: $130 · 2024: $124 · 2025: $53.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $386.48 | 2021-2025 | |
| Lucid Diagnostics INC. | $51.46 | 2021 | |
| Boston Scientific Corporation | $38.59 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $21.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.04 | 2021 | |
| Pfizer INC. | $17.53 | 2023 | |
| Novo Nordisk INC | $16.50 | 2021 | |
| Genentech USA, INC. | $14.21 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $13.93 | 2022 | |
| Organon LLC | $6.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.